This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Since generative AI products first emerged, the models’ capabilities have grown by leaps and bounds. Now, they can seemingly bring renowned scientists from the past back to life.
This care model has grown in popularity, with startups such as Prenuvo and Ezra charging $2,500 out of pocket to screen asymptomatic patients for cancer and other diseases
Digital breast tomosynthesis (DBT) increased breast cancer detection rates over a 10-year time period, researchers reported in a study published on September 17 in Radiology. A group led by Lianne Philpotts, MD, from Yale University in New Haven, CT, also found that DBT identifies invasive cancers with a lower rate of advanced cancers compared with digital mammography.
ACR noted that Congress is returning from its August recess, with one of the “most critical” considerations pertaining to government funding for fiscal 2025.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
AI can generate radiologic report impressions that are professionally and linguistically appropriate for a full spectrum of radiology examinations, according to a study published September 17 in Radiology. A team led by PhD candidate Lu Zhang of Shanghai Jiao Tong University in Shanghai, China, developed a large language model (LLM) that generates interpretations (“impressions”) on reports based on imaging findings and evaluated its performance in professional and linguistic dimensions.
“These findings suggest that changing the genetic testing paradigm to population-based testing could prevent thousands of breast and ovarian cancers," experts wrote in JAMA.
“These findings suggest that changing the genetic testing paradigm to population-based testing could prevent thousands of breast and ovarian cancers," experts wrote in JAMA.
The Global Ultrasound Institute (GUSI) has released Sage AI, an AI tool that answers open-ended ultrasound-related questions. Sage AI adds to GUSI's scanHub training platform, which aims to help healthcare practitioners gain competency in using point-of-care ultrasound (POCUS) across a range of medical specialties. Answers given by Sage AI are fully referenced, are accompanied by ultrasound images and video clips drawn from GUSI's pathology library, and can be delivered in more than 80 different
In a study involving over 272,000 breast cancer screening exams, digital breast tomosynthesis (DBT) had a higher breast cancer detection rate and a lower rate of advanced cancer presentation at the time of diagnosis in comparison to digital mammography.
Contrast-enhanced mammography (CEM)-guided biopsy by itself is not a good substitute for MRI-guided biopsy of suspicious breast MRI findings, according to a study published September 18 in the American Journal of Roentgenology. Researchers led by Michael Morris, MD, from Banner MD Anderson Cancer Center in Gilbert, AZ, reported that more than one-quarter of suspicious MRI findings deemed to be occult at attempted CEM-guided biopsy were diagnosed as malignant by subsequent MRI-guided biopsy.
Scientists share detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may accelerate the development of antivirals that target this viral structure to combat several filoviruses at once.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
An automated AI model can identify incidental, extrapulmonary structures on chest CT scans and thus help clinicians predict all-cause mortality risk, researchers have reported. A group led by Anna Marcinkiewicz, MD, PhD, of Cedars-Sinai Medical Center in Los Angeles found that the model predicted 10-year all-cause mortality with an area under the receiver operating curve (AUC) of 0.72 (p Radiology.
Radiomics models offered a pooled AUC of 86 percent for differentiating between ruptured and unruptured intracranial aneurysms, according to a recently published meta-analysis.
The RSNA's Research and Education Foundation has awarded more than $84 million in grant funding since its founding 40 years ago. To mark the milestone, the foundation is holding a "Week of Giving" through September 21, the day RSNA established it in 1984 with a $1 million donation. Contributions can be made online or by texting 40TH to 71777. Annual cumulative donations over $300 will be acknowledged at RSNA 2024, the RSNA said.
Providing automated TI-RADS classifications and worksheets, the new AI-enabled software may facilitate improved efficiency with thyroid ultrasound exams.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Canon Medical Systems has launched Canon Medical Academy in Cleveland, OH. Governor Mike DeWine attended the academy's opening. The academy will serve as a hub for training Canon customers on its technology and products and is located near Canon's research and development organization, Canon Medical Research. The facility will offer a curriculum designed by Canon experts and will bolster the local healthcare workforce, the company said.
According to a new 10-year study, screening for breast cancer with digital breast tomosynthesis (DBT) increases cancer detection rates and significantly reduces the rate of advanced cancers compared to conventional 2D digital mammography. The findings were published in Radiology.
A large independent cardiology practice in Salem, Oregon, has filed a $15 million antitrust and defamation lawsuit against local health system Salem Health, according to a September 16 article in the Salem Reporter. The Oregon Heart Center offers a range of cardiac care, including ultrasound, nuclear medicine and x-ray imaging. It claims that Salem Health "pressured patients while still in their hospital beds to switch providers, limited referrals and access to information about independent card
The RSNA 2024 Annual Meeting is right around the corner, and it’s shaping up to be a groundbreaking event for radiologists, medical professionals, and technology enthusiasts alike. Set to take place in Chicago, this year’s meeting will feature a diverse range of presentations, educational sessions, and networking opportunities. Among the many highlights, the AI Showcase promises to be a focal point for attendees interested in the cutting edge of artificial intelligence, machine learn
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
GE HealthCare’s (GEHC) MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to perform Centiloid scaling for PET-based amyloid imaging analysis and quantification. MIM Software may now offer its MIMneuro package with Centiloid scaling, which uses an automated workflow to help users determine the density of amyloid plaque in a patient’s brain, GEHC said.
As part of our celebration of Postdoc Appreciation Week, we invited two postdocs, Virginie Kreutzinger, MD, and Katharina Ziegeler, MD, to answer a few questions about their work and their time at UCSF.
AI ultrasound company See-Mode Technologies has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its thyroid ultrasound analysis and reporting software. The software helps reduce reporting time and mitigates operator experience variations for thyroid ultrasound, the company said. It detects nodules in single or multinodular thyroid ultrasound images and automatically classifies each according to the American College of Radiology’s (ACR) TI-RADS rating system, accord
New technologies developed by researchers may soon enhance ultrasound's effectiveness in diagnosing conditions such as cancer, liver disease, and other.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Butterfly Network is highlighting the results from a study that shows the potential of its point-of-care ultrasound (POCUS) devices and its enterprise ultrasound platform Compass. The study was established by a partnership the company entered with the University of Rochester Medical Center (URMC) in New York. Its findings were published September 16 in the Journal of Clinical Imaging Science.
Without question – remote work is the biggest labor force shift we’ve seen in decades. When it comes to its ramifications, the truth is, we just don’t know enough yet. We haven’t fully appreciated the impact that remote/in-office work has had on client companies, candidate careers and the economy as a whole. That’s why a lot of companies find themselves in a tricky “trilemma” – should they let their staff go fully-remote, hybrid or work in the office full-time?
Healthcare Administrative Partners (HAP) has added Mid Atlantic Radiology Consultants (MARC) in Langhorne, PA, to its roster of radiology revenue cycle management clients. Under the terms of the agreement, HAP will perform all core revenue cycle services on behalf of Mid Atlantic Radiology Consultants. This includes billing, coding, carrier credentialing, business intelligence, and MIPS Measure Assurance Services.
The HiRise is a low dose cone beam CT system. The upper extremity scans are quick and allow for patients to be scanned in a comfortable seated position. Common Indications Scaphoid Fracture A feasible alternative to MDCT for the detection of extremity fractures at a reduced radiation dose. 1 Distal Radius Fracture Post-operatively, CBCT can diagnose scaphoid union at an early follow-up and prevents longer immobilization and interruption of activity or work. 2 TFCC Tear Patient injected with 1cc
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content